IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS
• Year: 2005
Novartis li censed-in rights to de velop Takeda's Prevacid (lansoprazole) as an OTC prod uct in the USA and
its ter ri to ries.
Novartis agreed to sell its Nu tri tion et Sante unit to ABN AMRO Cap i tal France for $260 mil lion.
Novartis an nounced plans to move the HQ of its Sandoz unit to south ern Ger many from Aus tria as part of
an in te gra tion pro cess. The new HQ will be in Holzkirchen, Ba varia.
It was re ported that Novartis In dia is to trans fer its anti-TB rifampicin bulk drug busi ness, along with its
fa cil ity in Mahad (In dia) to the Sandoz generics unit of Novartis. In re turn, Novartis will pay the in de pend -
ently-owned Novartis In dia Rs307.7 million.
Novartis an nounced plans to in vest $4 mil lion in mod ern iz ing its two generics plants in Ar gen tina with the
aim of ex port ing to Eu rope. The main plant to be mod ern ized spe cial izes in on col ogy prod ucts, un der the
Sandoz name.
Ten com pa nies, in clud ing Novartis, be gan en roll ment on the To gether Rx Ac cess Card Pro gram, de signed
to aid un in sured Amer i cans gain better ac cess to pre scrip tion prod ucts. The par tic i pat ing com pa nies of fer
sav ings on more than 275 brand-name pre scrip tion drugs for those who meet in come and age eligibility
requirements.
• Year: 2004
Novartis an nounced plans to re struc ture its Sandoz unit to cut costs and im prove in te gra tion with the
par ent com pany.
Novartis an nounced plans to in vest around $180 mil lion in new bulk pro duc tion fa cil ity in Sin ga pore.
Lek opened a new Euro18 mil lion plant for biopharmaceuticals, Port1, in Menges, near the cap i tal
Ljubljana. Si mul ta neously, Sandoz opened a Euro50 mil lion plant for biopharmaceuticals in Aus tria and
the two fa cil i ties to gether will cre ate over 100 jobs and strengthen Sandoz’ franchise.
• Year: 2003
Novartis opened $122 mil lion In sti tute for Trop i cal Dis eases in Sin ga pore.
• Year: 2002
Novartis sold its food and bev er age busi ness to As so ci ated Brit ish Foods for Euro272.5 mil lion.
Novartis es tab lished the $250 mil lion Novartis In sti tute for Bio med i cal Re search, Inc. (NIBRI) in Cam -
bridge, Mas sa chu setts. NIBRI will be the new global R&D head quar ters of Novartis.
• Year: 2001
Novartis’ sub sid iary Biochemie opened the An ti bi otic Re search In sti tute (ABRI) in Vi enna.
• Year: 2000
Novartis un veiled a re struc tur ing and re or ga ni za tion of its phar ma ceu ti cal di vi sion. It was split into three
in de pend ent units: A Pri mary Care group; a Spe cialty busi ness; and a third in de pend ent busi ness unit
was also cre ated which con cen trates on the mar ket ing of slow-grow ing mature products.
© 2009 IMS Health In cor po rated or its af fil i ates Page 144